Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.

Abstract: An improved flowmeter for measuring the flow rate of a fluid in a fluid path is described. In the preferred embodiment, the flowmeter includes a housing having a longitudinal bore therein. A turbine assembly is supported for rotation in the longitudinal bore and includes one or more conductive blades. An inductor coil is supported adjacent the longitudinal bore, and an oscillator is coupled to the inductor coil for generating a signal of predetermined RF frequency in the inductor coil to induce a magnetic field in the bore. In operation, when the fluid is directed through the longitudinal bore, the blades of the turbine assembly are rotated at a speed proportional to flow rate to generate a sensed signal in the inductor coil. The sensed signal includes a low frequency amplitude-modulated signal component proportional to the flow rate of the fluid.

Abstract: A security terminal for use with a two-way interactive cable system. The security terminal develops alarm and supervisory signals, and controls their transmission over the cable when polled by a central station. The terminal discriminates between four different types of alarm condition (burglary, fire, medical and general emergency), and transmits respective coded signals over the cable, or over a switched telephone network if cable transmission is not successful. To further insure that alarm signals are properly transmitted in the event of a cable outage, the terminal responds to a cable-sent test command from the central station by causing the dialer to dial the central station over the switched telephone network; in this way, the dialer mechanism can be tested periodically to insure that it will be operative if needed.